BioCentury | May 6, 2020
Management Tracks
Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more
...March, raising $75.2 million in an IPO (see “Imara’s NASDAQ Debut” ). Genomic tools company RevoluGen Ltd....
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
